Drug Testing Locations - Franklin, IN

Drug Testing in Franklin, IN

Franklin, Indiana Statistics

In 2019, Franklin, IN, in Johnson County reported over 150 opioid-related hospital admissions.

Franklin, IN saw a 15% increase in drug-related arrests from 2018 to 2020.

In 2021, Johnson County reported an overdose rate of 25 per 100,000 in Franklin.

40% of substance abuse cases in Franklin, IN involved heroin as of 2019.

The youth substance use rate in Franklin decreased by 10% from 2015 to 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Franklin, IN & Drug Testing Policies

Employers in Franklin, IN, increasingly implement robust drug testing policies to maintain a safe workplace. Many align with guidelines from the U.S. Department of Labor to ensure compliance.

Companies frequently opt for random drug testing to deter drug use and safeguard their workforce from potential substance-related accidents. This not only aligns with industry best practices but is also incentivized by insurance benefits.

Major employers in Franklin often extend employee assistance programs (EAPs) to support workers struggling with substance use, promoting a proactive approach against drug abuse. Such initiatives are increasingly important in fostering a healthy work environment.

Government Efforts with Drug Problems in Franklin, IN

In recent years, Franklin, IN, has taken significant steps to combat the escalating drug abuse issue. The city collaborates with the Johnson County Sheriff's Office to implement targeted community outreach programs aimed at reducing substance abuse.

Additionally, state support through the Indiana State Department of Health provides resources for rehabilitation centers in Franklin. Federal grants have also bolstered local efforts by funding new initiatives for drug prevention and education.

Local Drug Busts & News in Franklin, IN

In Franklin, IN, recent efforts by local law enforcement have led to significant drug busts, targeting major distribution networks within the community. These operations are part of a concerted effort to curb the trafficking and usage of illicit substances locally, in response to rising concerns about public health and safety. Several arrests have been made, with law enforcement working diligently to dismantle these harmful supply chains.

One notable incident involved a coordinated raid on multiple locations suspected of being part of a drug ring operating within the county. This crackdown led to the seizure of considerable quantities of narcotics, ranging from methamphetamines to opioids. These substances were destined for distribution across the town, posing a threat to the well-being of Franklin's residents, especially its youth.

The increase in drug activity in Franklin has prompted local authorities to enhance community awareness programs. Education initiatives aim to inform residents about the dangers of substance abuse and the signs of drug activity in neighborhoods. The community is encouraged to report suspicious behavior, playing an active role in renewing Franklin's safety and ensuring that such illicit operations are swiftly addressed.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Franklin, IN. Trusted by employers nationwide for accurate results and exceptional service.

Indiana DOT/Non DOT Physicals

Indiana Vision Tests

Indiana Audiograms

Indiana Respirator Fit Tests

Indiana Lift Tests

Indiana Background Checks

Clinical Testing Services

TB Testing in IN

Diabetes Testing in IN

Infectious Disease Testing in IN

Sickle Cell Anemia Testing in IN

Women/Men's Health Testing in IN

Resources & Citations

Overdose Lifeline, Inc.

Indiana Recovery Network

Valley Prevention Services

Fairbanks Treatment Center

Indiana Division of Mental Health and Addiction

Headwaters Counseling

Evansville Psychiatric Children's Center

McGregor Institute of Peace

Centerstone Indiana

Valley Oaks Health

Drug Testing Near Franklin, IN

Homecroft, IN

Morgantown, IN

Southport, IN

Fairland, IN

Cordry Sweetwater Lakes, IN

Edinburgh, IN

Greenwood, IN

Princes Lakes, IN

Trafalgar, IN

Bargersville, IN

New Whiteland, IN

Whiteland, IN

Amity, IN

Frequently Asked Questions

Customer Reviews